D'ABUNDO, Lucilla
 Distribuzione geografica
Continente #
NA - Nord America 1.543
EU - Europa 589
AS - Asia 250
OC - Oceania 2
SA - Sud America 1
Totale 2.385
Nazione #
US - Stati Uniti d'America 1.543
PL - Polonia 282
CN - Cina 151
IT - Italia 123
UA - Ucraina 52
DE - Germania 37
GB - Regno Unito 36
TR - Turchia 34
SG - Singapore 32
SE - Svezia 28
FI - Finlandia 18
ID - Indonesia 16
VN - Vietnam 12
CZ - Repubblica Ceca 6
AU - Australia 2
FR - Francia 2
HK - Hong Kong 2
IN - India 2
RO - Romania 2
BE - Belgio 1
CL - Cile 1
ES - Italia 1
IR - Iran 1
NL - Olanda 1
Totale 2.385
Città #
Warsaw 282
Fairfield 246
Woodbridge 174
Ashburn 141
Houston 128
Seattle 115
Chandler 110
Wilmington 96
Cambridge 95
Ann Arbor 76
Jacksonville 69
Beijing 48
Ferrara 46
Nanjing 26
New York 26
Shanghai 26
Milan 22
Izmir 20
Singapore 20
Princeton 19
Jakarta 16
San Diego 13
Boardman 12
Nanchang 11
Dong Ket 10
Mountain View 9
Shenyang 8
Falls Church 7
Redwood City 7
Addison 6
Bologna 6
Bremen 6
Brno 6
Los Angeles 6
Dearborn 5
Hebei 5
London 5
Cagliari 4
Helsinki 4
Ningbo 4
Zhengzhou 4
Auburn Hills 3
Changsha 3
Jiaxing 3
Kunming 3
San Giorgio Di Piano 3
Washington 3
Cento 2
Des Moines 2
Focsani 2
Hanoi 2
Hong Kong 2
Hounslow 2
Lappeenranta 2
Monte San Pietro 2
Norwalk 2
Pasadena 2
Redmond 2
Tappahannock 2
Tianjin 2
Amsterdam 1
Andover 1
Ardabil 1
Augusta 1
Brussels 1
Canberra 1
Cassano Magnago 1
Chicago 1
Chiswick 1
Concepcion 1
Conegliano 1
Ferrara di Monte Baldo 1
Guangzhou 1
Hangzhou 1
Hefei 1
Jinan 1
Kilburn 1
Lanzhou 1
Leawood 1
Marseille 1
Monmouth Junction 1
Orange 1
Padova 1
Pavullo Nel Frignano 1
Pignone 1
Providence 1
Pune 1
Rome 1
San Mateo 1
Serra 1
Southend 1
Taizhou 1
Taranto 1
Trento 1
Venice 1
Zaragoza 1
Totale 2.019
Nome #
MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches 287
Studi pre-clinici per lo sviluppo di approcci terapeutici basati sui microRNA in un modello di Leucemia Linfatica Cronica 195
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model 168
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer 146
Anti-Tumor Activity of a miR-199-dependent Oncolytic Adenovirus 145
miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model 145
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 139
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 135
Cellular and Kaposi's sarcoma-associated herpes virus microRNAs in sepsis and surgical trauma 119
Combining anti-miR-155 with chemotherapy for the treatment of lung cancers 117
microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters 115
TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia 109
Epstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival 107
null 89
miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model 76
Mutated beta-catenin evades a microRNA-dependent regulatory loop 67
null 63
FOXP3 is a direct target of miR15a/16 in umbilical cord blood regulatory T cells 62
Signal transducer and activator of transcription (STAT)-3 regulates microRNA gene expression in chronic lymphocytic leukemia cells 57
Inhibiting the oncogenic mir-221 by microRNA sponge: Toward microRNA-based therapeutics for hepatocellular carcinoma 28
Erratum: miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models 24
Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with "Oncogene-Addicted" Advanced Lung Adenocarcinoma: A Real-World Clinical Study 23
miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs 18
A microRNA signature to predict risk progression of vulvar lichen sclerosus to squamous cell carcinoma 14
miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models 14
Circulating CD8 lymphocytes predict response to atezolizumab–bevacizumab in hepatocellular carcinoma 8
Totale 2.470
Categoria #
all - tutte 9.292
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.292


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020532 65 16 15 73 33 51 54 55 42 64 29 35
2020/2021619 37 61 135 48 27 57 29 42 20 106 39 18
2021/2022222 11 20 23 3 10 13 10 15 6 18 25 68
2022/2023246 19 19 12 29 44 33 17 17 30 3 13 10
2023/2024238 13 21 9 5 17 48 12 48 1 9 4 51
2024/202520 20 0 0 0 0 0 0 0 0 0 0 0
Totale 2.470